NCT00005830
- Conditions
- Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, +2 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
Clinical trial condition
Endometrial Clear Cell Adenocarcinoma
Explore clinical trials studying Endometrial Clear Cell Adenocarcinoma. Study availability and eligibility vary by location and protocol.
26 public trials
4 recruiting studies
Endometrial Clear Cell Adenocarcinoma trial results
NCT00005840
- Conditions
- Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer, +1 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
Active, Not Recruiting
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
NCT03914612
- Conditions
- Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, +30 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
NCT00977574
- Conditions
- Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, +7 more
- Locations
-
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
Active, Not Recruiting
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
NCT02142803
- Conditions
- Adnexal Diseases, Adult Glioblastoma, Astrocytoma, +47 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Charlestown, Massachusetts, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer
NCT01737619
- Conditions
- Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma, +8 more
- Locations
-
- Lyndon Baines Johnson General Hospital Houston, Texas, United States
- M D Anderson Cancer Center Houston, Texas, United States
- The Woman's Hospital of Texas Houston, Texas, United States
- MD Anderson Regional Care Center-Katy Houston, Texas, United States
Related conditions
- Endometrial Serous Adenocarcinoma (23)
- Endometrial Adenocarcinoma (15)
- Endometrial Adenosquamous Carcinoma (11)
- Endometrial Undifferentiated Carcinoma (10)
- Recurrent Uterine Corpus Carcinoma (10)
- Female Urogenital Diseases (8)
- Female Urogenital Diseases and Pregnancy Complications (8)
- Genital Diseases (8)